Objective To analyse the efficacy of methotrexate combined with mifepristone in treatment of 130 cases heterotopic pregnancy. Methods 130 cases heterotopic pregnancy from January 2014 to December 2014 in obstetrics and gynecology department of First Affiliated Hospital of Liaoning Medical University were divided into observation group and control group, randomly, 65 cases in each group.Patients in control group were treated with 1 mg/kg methotrexate of intramuscular injection, one time per day; patients in observation group were treated with mifepristone of oral, one time per day, 75mg per time on the basis of control group.The serum β-subunit of human chorionic gonadotropin (β-hCG), normal pregnancy rate, size of enclosed mass, rate of treatment success and adverse reactions in two groups were compared.Results The recovery time of serum β-HCG in observation group was shorter than that in control group ( P <0.05 ) , and normal pregnancy rate in observation group was higher than that in control group (P<0.05).After 7 and 14 days’ treatment, size of enclosed mass in observation group was smaller than that in control group (P<0.05).After two months’ treatment, the efficacy in observation group was higher than that in control group (92.31%vs.61.54%;χ2 =17.33,P<0.05).There was no significant difference in adverse reactions rate between two groups (χ2 =0.34,P>0.05).Conclusion Methotrexate combined with mifepristone could improve the clinical efficacy which is a safe therapy with few adverse reactions.

Purpose:Taking tuberculosis as an example, this paper aims at to analyzing the level of reimburse-ment for infectious diseases care, and clarifying the government responsibility. Methods:In order to achieve the ob-jective of this research, UHC framework was used to analyze the security level. Result:The findings of this research reveal that TB in-patients' Compensation Ratio of the New Cooperative Medical Scheme ( NCMS) was lower than aver-age level of all the NCMS patients, the out-patients' was even lower. The categories of anti-tuberculotic for free was limited, the utilization was not as expected. Medical assistance covered few people in spite of its high level of reim-bursement. Conclusion:Based on the findings of this review, it has been revealed that the medical insurance didn't make a big difference in financial protection for patients with infectious diseases. As the treatment for of infectious diseases is a quasi-public good, the government has to shoulder the responsibility of improving the compensation ratio of the patients.